Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study-Reference-Cited by-同舟云学术

Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study

Published:2020-12-07 Issue:5 Volume:87 Page:2236-2246
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Passot Christophe¹²³^ORCID,Sberro‐Soussan Rebecca⁴,Bertrand Dominique⁵,Caillard Sophie⁶,Schvartz Betoul⁷,Domenger Camille⁸,Contin‐Bordes Cécile⁹,Paintaud Gilles¹²,Halimi Jean‐Michel¹⁰¹¹,Ternant David¹²,Gatault Philippe¹⁰¹¹^ORCID

Affiliation:

1. EA7501 University of Tours France

2. Laboratory of Pharmacology‐Toxicology CHRU de Tours France

3. Integrated Center for Oncology Angers France

4. Service de Néphrologie et Transplantation Adulte, Hôpital Necker‐Enfants Malades Université Paris Descartes, Assistance Publique‐Hôpitaux de Paris Paris France

5. Department of Nephrology and Transplantation Centre Rouen France

6. Nephrology and Transplant Department Strasbourg University Hospital Strasbourg France

7. Nephrology and Transplant Department Reims France

8. Nephrology and Transplant Department Grenoble France

9. Laboratory of Immunology and Immunogenetic Bordeaux France

10. EA4245 Transplant Immunology and Inflammation Université de Tours Tours France

11. Service de Néphrologie‐Hypertension artérielle, Dialyses, Transplantation rénale CHRU Tours France

Funder

Ministère de l'Enseignement Supérieur et de la Recherche

Publisher

Wiley

Subject